QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 precipio-reports-03m-cash-generated-by-operations-in-q2-2024

Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), announces that its unaudited non-GAAP Cash Burn/Generated fr...

 precipio-reports-q2-2024-revenue-of-44m-vs-433m-est-expects-pathology-divisions-revenues-will-reach-more-than-15m-per-month-by-year-end

Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), announces that for Q2-2024, its unaudited revenues have grow...

Core News & Articles

Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO) announces it has entered into a distribution agreement with C...

 precipios-q4-2023-cash-burn-from-operations-drops-below-100k-for-the-full-quarter-precipios-end-of-quarter-cash-balance-changed-from-15m-at-the-end-of-q3-2024-to-14m-as-of-dec-31-2023

Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO) announces that continued revenue growth generated cash levels...

 precipio-signs-distribution-agreement-for-iv-cell-and-hemescreen-in-japan

Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO) announces it has entered into an agreement with a Japanese di...

 precipio-sees-q3-revenue-45m-vs-4m-est

Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), announces that Q3-2023 (unaudited) revenues have increased 2...

 precipio-inc-has-regained-compliance-with-nasdaq-bid-price-rule

- SEC Filing

 precipio-continues-to-sign-new-hemescreen-customers-expected-to-bring-total-q4-hemescreen-revenues-to-an-estimated-12m

Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO) announced that new customer orders are expected to bring tota...

 precipio-reduces-product-revenue-result-needed-for-cash-flow-breakeven-from-8m-to-6m-annually-or-15m-per-quarter-25-below-previous-estimates

Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO) announced that due to the increased pathology revenue, and th...

 stocks-that-hit-52-week-lows-on-thursday

  During the session on Thursday, 461 stocks hit new 52-week lows.

 stocks-that-hit-52-week-lows-on-monday

  Monday's session saw 175 companies set new 52-week lows.

 precipios-earnings-a-preview
Precipio's Earnings: A Preview
08/16/2023 16:01:00

 precipio-launches-quantitative-bcr-abl-20-panel

The following features make this product the most advanced BCR-ABL panel on the market, besting competition in terms of robust ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION